{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-03-18",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Bridgewater",
      "state": "NJ",
      "country": "United States",
      "classification": "Class III",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "77478",
      "recalling_firm": "Sanofi-Aventis U.S. LLC",
      "address_1": "55 Corporate Dr",
      "address_2": "N/A",
      "postal_code": "08807-1265",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "Nationwide in the USA, Puerto Rico, and the United Kingdom.",
      "recall_number": "D-0926-2017",
      "product_description": "Gaviscon (Alumina & Magnesium Trisilicate) Regular Strength Original Flavor Chewable Tablets, 80 mg & 14.2 mg, 100-count bottles, Distributed by: GlaxoSmithKline Consumer Healthcare, L.P.,  Moon Twp, PA 15108, UPC 3 0088-1175-47 8.",
      "product_quantity": "2980 bottles",
      "reason_for_recall": "Superpotent Drug: high out-of-specification result for magnesium.",
      "recall_initiation_date": "20170612",
      "center_classification_date": "20170629",
      "termination_date": "20190207",
      "report_date": "20170705",
      "code_info": "Lot #: 5J69A, Exp 02/19; 6GF2A, 6GF3A, Exp 08/19"
    }
  ]
}